Current issues in Sjögren's syndrome.

Sjögren's syndrome is a chronic autoimmune and rheumatic disorder with prominent sicca complaints from the mucous membranes because of lack of proper exocrine secretions. There is no straightforward and simple diagnostic test for Sjögren's syndrome, although several classification criteria have been designed including several oral diagnostic tests. A new set of classification criteria in a joint effort by research groups in Europe and USA has recently been presented. A large number of autoantibodies have been reported in Sjögren's syndrome where, in some cases, the antibodies are correlated with the extent and severity of disease. The finding of serum autoantibodies directed against the muscarinic M3 receptor is an important advance in understanding the pathogenesis of not only the impaired glandular function but also associated features of autonomic dysfunction in some patients. The treatment of primary Sjögren's syndrome is still mainly symptomatic.

[1]  R. Jonsson,et al.  Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: a Possible Mechanism in the Pathogenesis of Sjögren's Syndrome , 2002, Scandinavian journal of immunology.

[2]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[3]  M. Wahren-Herlenius,et al.  Expression of the B Cell‐Attracting Chemokine CXCL13 in the Target Organ and Autoantibody Production in Ectopic Lymphoid Tissue in the Chronic Inflammatory Disease Sjögren's Syndrome , 2002, Scandinavian journal of immunology.

[4]  A. Vissink,et al.  Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome , 2002, Annals of the rheumatic diseases.

[5]  R. Jonsson,et al.  Up-regulation of M3-Muscarinic Receptors in Labial Salivary Gland Acini in Primary Sjögren's Syndrome , 2002, Laboratory Investigation.

[6]  B. Nakken,et al.  The genetic control of sialadenitis versus arthritis in a NOD.Q×B10.Q F2 cross , 2002, European journal of immunology.

[7]  A. Vissink,et al.  Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome , 2001, Annals of the rheumatic diseases.

[8]  I. Suramo,et al.  Magnetic resonance imaging and magnetic resonance sialography of parotid glands in primary Sjogren's syndrome. , 2001, Arthritis and rheumatism.

[9]  B. Nakken,et al.  Associations of MHC Class II Alleles in Norwegian Primary Sjögren's Syndrome Patients: Implications for Development of Autoantibodies to the Ro52 Autoantigen , 2001, Scandinavian journal of immunology.

[10]  J. Harley,et al.  Role of viruses in systemic lupus erythematosus and Sjögren syndrome. , 2001, Current opinion in rheumatology.

[11]  R. Jonsson,et al.  HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. , 2001, The Journal of rheumatology.

[12]  S. Bowman,et al.  Chemokines and Cell Trafficking in Sjögren's Syndrome , 2001, Scandinavian journal of immunology.

[13]  A. Tzioufas,et al.  "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. , 2001, Arthritis and rheumatism.

[14]  R. Jonsson,et al.  Autoantibodies in Primary Sjögren's Syndrome: New Insights into Mechanisms of Autoantibody Diversification and Disease Pathogenesis , 2001, Autoimmunity.

[15]  A. Bradwell,et al.  Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms. , 2000, The Journal of rheumatology.

[16]  M. Rischmueller,et al.  Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. , 2000, Arthritis and rheumatism.

[17]  R. Jonsson,et al.  Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome , 2000, Scandinavian journal of rheumatology.

[18]  Y. Inagaki,et al.  A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases. , 1999, Journal of dermatological science.

[19]  D. Isenberg,et al.  Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. , 1999, Arthritis and rheumatism.

[20]  Jonsson,et al.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation , 1999, Clinical and experimental immunology.

[21]  A. Rubinow,et al.  The use of oral pilocarpine in xerostomia and Sjögren's syndrome. , 1999, Seminars in arthritis and rheumatism.

[22]  C. Vitali,et al.  Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. , 1999, The Journal of rheumatology.

[23]  S. Pillemer,et al.  Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992. , 1999, The Journal of rheumatology.

[24]  R. Jonsson,et al.  Increased Frequency of Cells Secreting Interleukin‐6 and Interleukin‐10 in Peripheral Blood of Patients with Primary Sjögren's Syndrome , 1999, Scandinavian journal of immunology.

[25]  Y. Hayashi,et al.  Anti–α-Fodrin Antibodies in Sjögren Syndrome and Lupus Erythematosus , 1999 .

[26]  Richard E. Watts,et al.  Autoimmune Rheumatic Disease , 1999 .

[27]  A. Sendelhofert,et al.  Lymphoepithelial duct lesions in Sjögren-type sialadenitis , 1999, Virchows Archiv.

[28]  P. Kloetzel,et al.  Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the α and β type , 1999 .

[29]  I. Griffiths,et al.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. , 1999, Rheumatology.

[30]  H. Moutsopoulos,et al.  Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. , 1999, Arthritis and rheumatism.

[31]  Jonsson,et al.  Ro/SS‐A‐reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome , 1999, Clinical and experimental immunology.

[32]  R. Jonsson,et al.  An Alternative Perspective to the Immune Response in Autoimmune Exocrinopathy: Induction of Functional Quiescence Rather Than Destructive Autoaggression , 1999, Scandinavian journal of immunology.

[33]  M. García-Carrasco,et al.  Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. , 1998, British journal of rheumatology.

[34]  R. Jonsson,et al.  Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. , 1998, Arthritis and rheumatism.

[35]  D. Isenberg,et al.  Predictors of lymphoma development in primary Sjögren's syndrome. , 1998, Seminars in arthritis and rheumatism.

[36]  Eguchi,et al.  Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus‐I (HTLV‐I)‐seronegative and ‐seropositive SS patients , 1998, Clinical and experimental immunology.

[37]  R. Jonsson,et al.  Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Shirai,et al.  Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. , 1998, Arthritis and rheumatism.

[39]  Coates,et al.  HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS) , 1998, Clinical and experimental immunology.

[40]  M. Yaron,et al.  Saliva: an additional diagnostic tool in Sjögren's syndrome. , 1997, Seminars in arthritis and rheumatism.

[41]  R. Jonsson,et al.  Lymphoid Cell Accumulation in Salivary Glands of Autoimmune MRL Mice Can be Due to Impaired Apoptosis , 1997, Scandinavian journal of immunology.

[42]  Y. Hayashi,et al.  Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. , 1997 .

[43]  A. Gabrielli,et al.  Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. , 1997, British journal of rheumatology.

[44]  S. Swerdlow,et al.  Salivary gland lymphoid infiltrates associated with lymphoepithelial lesions: a clinicopathologic, immunophenotypic, and genotypic study. , 1997, Human pathology.

[45]  Y. Hayashi,et al.  Identification of α-Fodrin as a Candidate Autoantigen in Primary Sjögren's Syndrome , 1997 .

[46]  M. García-Carrasco,et al.  Hepatitis C virus infection in ‘primary’ Sjögren’s syndrome: prevalence and clinical significance in a series of 90 patients , 1997, Annals of the rheumatic diseases.

[47]  C. Ross,et al.  Analysis of immunoglobulin heavy chain gene rearrangement in myoepithelial sialadenitis by polymerase chain reaction. , 1996, American journal of clinical pathology.

[48]  J. Partanen,et al.  Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. , 1996, Arthritis and rheumatism.

[49]  C. Sollerman,et al.  Expression of the mucosal lymphocyte integrin alpha E beta 7 and its ligand E-cadherin in the synovium of patients with rheumatoid arthritis. , 1996, Scandinavian journal of immunology.

[50]  Koji Sato,et al.  Seroprevalence of Helicobacter pylori Infection in Patients with Connective Tissue Diseases , 1996, Microbiology and immunology.

[51]  E. Borda,et al.  Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome , 1996, Clinical and experimental immunology.

[52]  C. di Loreto,et al.  Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. , 1996, Gastroenterology.

[53]  R. Fox,et al.  Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study , 1996, Lupus.

[54]  A. Tzioufas,et al.  Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. , 1996, Arthritis and rheumatism.

[55]  M. Hollingsworth,et al.  Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. , 1996, Gastroenterology.

[56]  P. Banks,et al.  Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. , 1996, Seminars in arthritis and rheumatism.

[57]  C. Bucca,et al.  Respiratory function in systemic lupus erythematosus: relation with activity and severity , 1996, Lupus.

[58]  R. Jonsson,et al.  Serum Antibodies from Patients with Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus Recognize Multiple Epitopes on the La(SS‐B) Autoantigen Resembling Viral Protein Sequences , 1996, Scandinavian journal of immunology.

[59]  H. Ménard,et al.  Purification of antigenically intact Ro ribonucleoproteins; biochemical and Immunological evidence that the 52‐kD protein is not a Ro protein , 1995, Clinical and experimental immunology.

[60]  P. Speight,et al.  Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development. , 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[61]  P. Speight,et al.  B‐Cell Monoclonality, Epstein Barr Virus, and t(14; 18) in Myoepithelial Sialadenitis and Low‐Grade B‐Cell MALT Lymphoma of the Parotid Gland , 1995, The American journal of surgical pathology.

[62]  D. Isenberg,et al.  Role of the Biologics in Autoimmunity , 1994, Lupus.

[63]  S. Bombardieri,et al.  The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. , 1994, Annals of the rheumatic diseases.

[64]  R. Jonsson,et al.  MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. , 1994, Immunology.

[65]  I. Weissman,et al.  Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. , 1994, Arthritis and rheumatism.

[66]  J. Whitcher,et al.  Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. , 1994, Arthritis and rheumatism.

[67]  R. Warnke,et al.  Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[68]  R. Jonsson,et al.  Progression of sialadenitis in Sjögren's syndrome. , 1993, British journal of rheumatology.

[69]  C. Pease,et al.  Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome. , 1993, British journal of rheumatology.

[70]  A. van der Heide,et al.  Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. , 1993, Annals of the rheumatic diseases.

[71]  S. Sawada,et al.  Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. , 1993, Journal of immunology.

[72]  P. Fox,et al.  Prednisone and piroxicam for treatment of primary Sjögren's syndrome. , 1993, Clinical and experimental rheumatology.

[73]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[74]  W. Travis,et al.  Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. , 1992, Arthritis and rheumatism.

[75]  R. Fox.  Treatment of the patient with Sjögren's syndrome. , 1992, Rheumatic diseases clinics of North America.

[76]  J. McCluskey,et al.  Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera. , 1992, Arthritis and rheumatism.

[77]  D. Pateron,et al.  Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease , 1992, The Lancet.

[78]  T. Sumida,et al.  T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. , 1992, The Journal of clinical investigation.

[79]  W. Dick,et al.  Primary Sjögren's syndrome in north east England--a longitudinal study. , 1991, British journal of rheumatology.

[80]  Y. Hamasaki,et al.  A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome. , 1991, Journal of dermatological science.

[81]  J. A. Burch,et al.  Anti-La antibody production by MRL-1pr/1pr mice. Analysis of fine specificity. , 1991, Journal of immunology.

[82]  J. Reveille.  The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome , 1990, Current opinion in rheumatology.

[83]  W. Travis,et al.  IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome. , 1989, The Journal of rheumatology.

[84]  R. Maini,et al.  Autoantibody synthesis in salivary glands of Sjögren's syndrome patients. , 1989, Journal of autoimmunity.

[85]  J. Reveille,et al.  Genetic studies in Sjögren's syndrome and systemic lupus erythematosus. , 1989, Journal of autoimmunity.

[86]  S. Avrameas,et al.  Natural autoantibodies in nude and normal outbred (Swiss) and inbred (BALB/c) mice. , 1989, Journal of autoimmunity.

[87]  C. Pease,et al.  Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome? , 1989, Clinical and experimental rheumatology.

[88]  P. Isaacson,et al.  Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. , 1988, Human pathology.

[89]  K. Sullivan,et al.  A 52-kD protein is a novel component of the SS-A/Ro antigenic particle , 1988, The Journal of experimental medicine.

[90]  N. Talal,et al.  B cells expressing CD5 are increased in Sjögren's syndrome. , 1988, Arthritis and rheumatism.

[91]  M. Hochberg,et al.  Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. , 1988, Arthritis and rheumatism.

[92]  A. Drosos,et al.  HLA-alloantigen associations in Greek patients with Sjögren's syndrome. , 1988, Journal of autoimmunity.

[93]  R. Jonsson,et al.  Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. , 1987, Clinical immunology and immunopathology.

[94]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue , 1987, Histopathology.

[95]  C. Dawes.  Physiological Factors Affecting Salivary Flow Rate, Oral Sugar Clearance, and the Sensation of Dry Mouth in Man , 1987 .

[96]  A. Tzioufas,et al.  Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. , 1986, Arthritis and rheumatism.

[97]  F. Arnett,et al.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. , 1986, Science.

[98]  C. Robinson,et al.  Sjögren's syndrome. Proposed criteria for classification. , 1986, Arthritis and rheumatism.

[99]  D. Carson,et al.  Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. , 1986, Journal of immunology.

[100]  J. Reveille,et al.  Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. , 1984, Annals of internal medicine.

[101]  T. Daniels.  Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. , 1984, Arthritis and rheumatism.

[102]  R. Akın,et al.  Sj??gren??s syndrome , 1975 .

[103]  E. Tan,et al.  Antibodies to cellular antigens in Sjögren's syndrome. , 1975, The Journal of clinical investigation.

[104]  T. Tomasi,et al.  Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. , 1969, Journal of immunology.

[105]  R. B. Goudie,et al.  Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. , 1967, Annals of the rheumatic diseases.

[106]  E. Cadman,et al.  Sjögren's Syndrome , 1953, Medicine illustrated.

[107]  C. Gordon,et al.  Candidate T cell epitopes of the human La/SSB autoantigen. , 2002, Arthritis and rheumatism.

[108]  R. Jonsson,et al.  Fas-Induced Apoptosis Is a Rare Event in Sjögren’s Syndrome , 2001, Laboratory Investigation.

[109]  L. Jacobsson,et al.  Seroprevalence of Helicobacter pylori in primary Sjögren's syndrome. , 2001, Clinical and experimental rheumatology.

[110]  A. B. Richards,et al.  Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[111]  N. Harris.  Lymphoid proliferations of the salivary glands. , 1999, American journal of clinical pathology.

[112]  E. Borda,et al.  Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. , 1998, Investigative ophthalmology & visual science.

[113]  R. Jonsson,et al.  Expression of the mucosal lymphocyte integrin alphaEbeta7 and its ligand E-cadherin in salivary glands of patients with Sjögren's syndrome. , 1998, Scandinavian journal of rheumatology.

[114]  R. Jonsson,et al.  A novel NOD-derived murine model of primary Sjögren's syndrome. , 1998, Arthritis and rheumatism.

[115]  N. Ogawa,et al.  Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. , 1997, Arthritis and rheumatism.

[116]  R. Jonsson,et al.  Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens. , 1996, Autoimmunity.

[117]  J. McCluskey,et al.  SS-B (La) Autoantibodies , 1996 .

[118]  R. H. Scofield,et al.  SS-A (Ro) Autoantibodies , 1996 .

[119]  C. Vindigni,et al.  Sjogren's syndrome and Helicobacter pylori infection , 1994 .

[120]  C. Vindigni,et al.  Sjörgren's syndrome and Helicobacteur pylori infection , 1994 .

[121]  A. Tzioufas,et al.  Sjögren’s Syndrome: From Polyclonal B Cell Activation to Monoclonal B Cell Proliferation , 1994 .

[122]  L. Jacobsson,et al.  Salivary gland scintigraphy in subjects with and without symptoms of dry mouth and/or eyes, and in patients with primary Sjögren's syndrome. , 1994, Scandinavian journal of rheumatology.

[123]  F. Breedveld,et al.  Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. , 1993, Clinical immunology and immunopathology.

[124]  G. Nepom.  MHC and autoimmune diseases. , 1993, Immunology series.

[125]  E. Csernok,et al.  ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. , 1993, Advances in experimental medicine and biology.

[126]  Yoshiya Tanaka,et al.  A PRELIMINARY STUDY ON THE INTERFERON-α TREATMENT FOR XEROSTOMIA OF SJÖGREN'S SYNDROME , 1993 .

[127]  N. Gt.  MHC and autoimmune diseases. , 1993 .

[128]  K. Shiozawa,et al.  A preliminary study on the interferon-alpha treatment for xerostomia of Sjögren's syndrome. , 1993, British journal of rheumatology.

[129]  H. Erlich,et al.  Specific hla‐dqa and hla‐drb1 alleles confer susceptibility to sjögren's syndrome and autoantibody production , 1991, Journal of clinical laboratory analysis.

[130]  H. Moutsopoulos,et al.  Immunopathogenesis of Sjogren's syndrome: "facts and fancy". , 1989, Autoimmunity.

[131]  T. Daniels.  Salivary histopathology in diagnosis of Sjögren's syndrome. , 1986, Scandinavian journal of rheumatology. Supplement.

[132]  N. Morling,et al.  HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. , 1981, Scandinavian journal of rheumatology.

[133]  R. Manthorpe,et al.  Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). , 1979, Scandinavian journal of rheumatology.

[134]  T. Feltkamp,et al.  Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. , 1968, Clinical and experimental immunology.

[135]  H. Sjogren.  Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tranendrusen) , 1933 .